154 related articles for article (PubMed ID: 6134651)
1. Endocrine responses of type 1 (insulin-dependent) diabetic patients following successful pancreas transplantation.
Pozza G; Traeger J; Dubernard JM; Secchi A; Pontiroli AE; Bosi E; Malik MC; Ruitton A; Blanc N
Diabetologia; 1983 Apr; 24(4):244-8. PubMed ID: 6134651
[TBL] [Abstract][Full Text] [Related]
2. Metabolic and hormonal studies of type 1 (insulin-dependent) diabetic patients after successful pancreas and kidney transplantation.
Landgraf R; Nusser J; Riepl RL; Fiedler F; Illner WD; Abendroth D; Land W
Diabetologia; 1991 Aug; 34 Suppl 1():S61-7. PubMed ID: 1936698
[TBL] [Abstract][Full Text] [Related]
3. Determinants of a normal (versus impaired) oral glucose tolerance after combined pancreas-kidney transplantation in IDDM patients.
Pfeffer F; Nauck MA; Benz S; Gwodzinski A; Zink R; Büsing M; Becker HD; Hopt UT
Diabetologia; 1996 Apr; 39(4):462-8. PubMed ID: 8777996
[TBL] [Abstract][Full Text] [Related]
4. Normalization of insulin sensitivity and glucose homeostasis in type I diabetic pancreas transplant recipients: a 48-month cross-sectional study--a clinical research center study.
Cottrell DA
J Clin Endocrinol Metab; 1996 Oct; 81(10):3513-9. PubMed ID: 8855794
[TBL] [Abstract][Full Text] [Related]
5. Reversal of the enhanced somatostatin release from the isolated, perfused diabetic rat pancreas after the amelioration of diabetes by whole pancreas transplantation.
Kadowaki S; Taminato T; Chiba T; Goto Y; Nozawa M; Seino Y; Matsukura S; Fujita T
Diabetes; 1980 Sep; 29(9):742-6. PubMed ID: 6108274
[TBL] [Abstract][Full Text] [Related]
6. Insulin response to glucagon with or without tolbutamide in normal and diabetic subjects.
Chiba M; Ohneda A; Sakai T; Goto Y
Tohoku J Exp Med; 1982 Feb; 136(2):169-75. PubMed ID: 7041329
[TBL] [Abstract][Full Text] [Related]
7. Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance.
Lanng S; Thorsteinsson B; Røder ME; Orskov C; Holst JJ; Nerup J; Koch C
Acta Endocrinol (Copenh); 1993 Mar; 128(3):207-14. PubMed ID: 8480468
[TBL] [Abstract][Full Text] [Related]
8. Effect of tolbutamide on insulin, glucagon, and somatostatin release from the diabetic rat pancreas with special reference to glucose concentration.
Kadowaki S; Taminato T; Chiba T; Nozawa M; Fujita T; Norman AW
Endocrinology; 1983 Jun; 112(6):2187-92. PubMed ID: 6133743
[TBL] [Abstract][Full Text] [Related]
9. Effects of arginine and arginine plus somatostatin infusion on insulin release in diabetic patients submitted to pancreas allotransplantation.
Secchi A; Pontiroli AE; Bosi E; Piatti PM; Touraine JL; Monti LD; Gelet A; Traeger J; Dubernard JM; Pozza G
Diabete Metab; 1987; 13(4):422-5. PubMed ID: 2890540
[TBL] [Abstract][Full Text] [Related]
10. First peak insulin release after intravenous glucose and arginine is maintained for up to 3 years after segmental pancreas transplantation.
Secchi A; Martinenghi S; Caldara R; La Rocca E; Di Carlo V; Pozza G
Diabetologia; 1991 Aug; 34 Suppl 1():S53-6. PubMed ID: 1936696
[TBL] [Abstract][Full Text] [Related]
11. Combined pancreas and kidney transplantation in a lean type 2 diabetic patient. Effects on insulin secretion and sensitivity.
Pox C; Ritzel R; Büsing M; Meier JJ; Klempnauer J; Schmiegel W; Nauck MA
Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):420-4. PubMed ID: 12518254
[TBL] [Abstract][Full Text] [Related]
12. Effects of somatostatin on insulin and glucagon in patients with insulinoma.
Fallucca F; Mirabella C; Tamburrano G; Gambardella S; Aufieri G; Barbetti F; Andreani D
J Endocrinol Invest; 1979; 2(3):257-60. PubMed ID: 231062
[TBL] [Abstract][Full Text] [Related]
13. Insulin and glucagon response in patients with chronic pancreatitis.
Ohneda A; Kai Y; Ishii S; Matsuda K; Horigome K
Tohoku J Exp Med; 1976 Nov; 120(3):287-98. PubMed ID: 996852
[TBL] [Abstract][Full Text] [Related]
14. Carbohydrate intolerance in gonadal dysgenesis: evidence for insulin resistance and hyperglucagonemia.
Costin G; Kogut MD
Horm Res; 1985; 22(4):260-9. PubMed ID: 3908274
[TBL] [Abstract][Full Text] [Related]
15. Serum glucagon after arginine infusion in aged and young subjects.
Ferrero E; Casale G; De Nicola P
J Am Geriatr Soc; 1980 Jun; 28(6):285-7. PubMed ID: 6989881
[TBL] [Abstract][Full Text] [Related]
16. Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients.
Mortimer CH; Tunbridge WM; Carr D; Yeomans L; Lind T; Coy DH; Bloom SR; Kastin A; Mallinson CN; Besser GM; Schally AV; Hall R
Lancet; 1974 Apr; 1(7860):697-701. PubMed ID: 4132421
[No Abstract] [Full Text] [Related]
17. Does glucagon stimulation predict oral glucose tolerance in patients after simultaneous pancreas-kidney transplantation?
Nauck MA; Pfeffer F; Erb M; Müller T; Benz S; Schmiegel W; Hopt U
Transplantation; 2000 Aug; 70(3):545-7. PubMed ID: 10949203
[TBL] [Abstract][Full Text] [Related]
18. Abnormalities of endogenous glucagon and insulin in unstable diabetes.
Reynolds C; Molnar GD; Horwitz DL; Rubenstein AH; Taylor WF; Jiang NS
Diabetes; 1977 Jan; 26(1):36-45. PubMed ID: 830563
[TBL] [Abstract][Full Text] [Related]
19. Analysis of insulin secretion based on changes in plasma insulin and C-peptide in man.
Sakai T; Ohneda A; Nihei J; Kobayashi T
Tohoku J Exp Med; 1982 Dec; 138(4):427-40. PubMed ID: 6761899
[TBL] [Abstract][Full Text] [Related]
20. The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients.
Hansen AP; Christensen SE; Lundbaek K
Scand J Clin Lab Invest; 1975 May; 35(3):205-10. PubMed ID: 1153917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
